ArticleTranslational medicine communications2021

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing.

Kar Muthumani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.